Atlas Trials

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions

Clinical trial NCT02939859 · WITHDRAWN

Trial details

NCT number
NCT02939859
Sponsor
Healeon Medical Inc
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple SclerosisAutoimmune
Start date
2018-12-15
Primary completion
2022-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.